News from immunocellular therapeutics, ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 19, 2015, 06:00 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on May 28th

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of...

May 11, 2015, 16:01 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics Announces First Quarter 2015 Financial Results

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced financial results for the first quarter 2015.  "During...

May 11, 2015, 08:40 ET
View investor presentations 24/7 at www.virtualinvestorconferences.com.

ImmunoCellular Therapeutics Presentation Now Available for On-Demand Viewing

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation...

May 05, 2015, 08:30 ET
View investor presentations 24/7 at www.virtualinvestorconferences.com.

ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7

Company invites individual and institutional investors to attend interactive real-time virtual roadshow  ImmunoCellular Therapeutics,...

Apr 30, 2015, 06:00 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics to Report First Quarter 2015 Financial Results on May 11, 2015; Conference Call and Webcast to be Held on May 12, 2015

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report financial results for the first...

Mar 19, 2015, 06:00 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics Establishes Manufacturing Agreement with PharmaCell B.V. for European Production of ICT-107 for Phase 3 Registration Trial

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced the establishment of an agreement with PharmaCell B.V....

Mar 09, 2015, 16:01 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2014 Financial Results

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced financial results for the fourth quarter and year ended...

Mar 03, 2015, 06:00 ET
ImmunoCellular Therapeutics Logo

ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of...

Mar 02, 2015, 06:00 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report financial results for the year ended...

Feb 18, 2015, 16:05 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics Strengthens Executive Management Team with Appointment of Dr. Steven Swanson to Lead Stem-to-T-Cell Program

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced the appointment of Steven J. Swanson, PhD, as...

Feb 12, 2015, 08:06 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics, Ltd. Announces Pricing of a Public Offering of Common Stock and Warrants

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it has priced an underwritten public offering of an...

Jan 28, 2015, 06:00 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics to Present at the BIO CEO & Investor Conference on February 9, 2015

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer, will...

Dec 17, 2014, 06:00 ET
ImmunoCellular Therapeutics Logo

ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) announced that the US Patent and Trademark Office (USPTO) has issued a...

Dec 01, 2014, 06:00 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics Receives Positive Regulatory Feedback from European Medicines Agency on Advancing ICT-107 to Phase III Program

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that the European Medicines Agency (EMA) has provided...

Nov 14, 2014, 06:00 ET
ImmunoCellular Therapeutics Logo.

ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data at the Society for Neuro-Oncology Annual Meeting 2014

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT:IMUC) announces the presentation today of updated efficacy data from the phase II...

Nov 10, 2014, 06:00 ET
ImmunoCellular Therapeutics Logo

ImmunoCellular Therapeutics Announces Third Quarter 2014 Financial Results

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced financial results for the quarter ended September 30,...

Sep 26, 2014, 06:00 ET
ImmunoCellular Therapeutics Logo.  (PRNewsFoto/ImmunoCellular Therapeutics)

ImmunoCellular Therapeutics to Present at Livingston Securities Conference on October 1, 2014

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer, will...

Sep 24, 2014, 06:00 ET
ImmunoCellular Therapeutics Logo.  (PRNewsFoto/ImmunoCellular Therapeutics)

ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) announced today that it has established a licensing agreement with the...

Sep 17, 2014, 06:00 ET
ImmunoCellular Therapeutics Logo.  (PRNewsFoto/ImmunoCellular Therapeutics)

ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) provides a corporate update on its plans to advance ICT-107 to a...

Aug 07, 2014, 16:05 ET
ImmunoCellular Therapeutics Logo.  (PRNewsFoto/ImmunoCellular Therapeutics)

ImmunoCellular Therapeutics Announces Second Quarter 2014 Financial Results

ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced financial results for the quarter ended June 30, 2014. ...